BVGH will promote these business instances to catalyze product advancement among businesses with relevant technologies. Recognizing the urgent dependence on capital to aid product development, BVGH is usually creating a fresh vehicle for funding. Using its innovative model of non-profit sponsorship, grants administration and industrial knowledge, BVGH will recognize and seek financing for the most promising item development tasks in the field and is normally establishing a new system for foundations and various other donors to purchase these efforts. BVGH shall publish a quarterly newsletter, BVGH Record, to serve as a source for biotechnology companies, traders and public-private partnerships focusing on global health issues, and is usually launching its site at The theory for BVGH grew out of discussions with businesses and foundations pursuing BIO and the Gates Foundation’s Partnering for Global Wellness meeting in late 2002.Dr Mace Rothenberg, senior vice president, Clinical Development and Medical Affairs, and chief medical officer, Pfizer Oncology, said: Pfizer is definitely committed to working with partners all over the world to boost the advancement of oncology therapies, and we are proud to become partnering with Cancer Research UK and AstraZeneca upon this important trial. As our knowledge of tumor biology has evolved, we have discovered that targeting the genetic abnormalities within a cancer tumor can lead to meaningful improvements in look after that disease. Today, the research community is grappling with efficient and effective way to conduct medical trials and deliver new medicines to patients in this new world of stratified medicine.